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http:WHAT THIS PAPER ADDS
There are currently no widely used risk prediction models in elective abdominal aortic aneurysm (AAA) repair.
This study validates three risk prediction models for in-hospital mortality. Overall, all models demonstrated good
performance and are potentially useful. The British Aneurysm Repair (BAR) score, which was developed using
the UK National Vascular Database, has a number of advantages over the other models, including being
developed on the most contemporaneous data, excellent discriminatory ability overall, and good performance in
procedural subgroups. Validated risk prediction models such as the BAR score can facilitate clinical decision
making, improve informed consent, and risk-adjust elective AAA repair outcome data.Objective/background: A number of contemporary risk prediction models for mortality following elective
abdominal aortic aneurysm (AAA) repair have been developed. Before a model is used either in clinical practice
or to risk-adjust surgical outcome data it is important that its performance is assessed in external validation
studies.
Methods: The British Aneurysm Repair (BAR) score, Medicare, and Vascular Governance North West (VGNW)
models were validated using an independent prospectively collected sample of multicentre clinical audit data.
Consecutive, data on 1,124 patients undergoing elective AAA repair at 17 hospitals in the north-west of England
and Wales between April 2011 and March 2013 were analysed. The outcome measure was in-hospital mortality.
Model calibration (observed to expected ratio with chi-square test, calibration plots, calibration intercept and
slope) and discrimination (area under receiver operating characteristic curve [AUC]) were assessed in the overall
cohort and procedural subgroups.
Results: The mean age of the population was 74.4 years (SD 7.7); 193 (17.2%) patients were women and the
majority of patients (759, 67.5%) underwent endovascular aneurysm repair. All three models demonstrated good
calibration in the overall cohort and procedural subgroups. Overall discrimination was excellent for the BAR score
(AUC 0.83, 95% conﬁdence interval [CI] 0.76e0.89), and acceptable for the Medicare and VGNW models, with
AUCs of 0.78 (95% CI 0.70e0.86) and 0.75 (95% CI 0.65e0.84) respectively. Only the BAR score demonstrated
good discrimination in procedural subgroups.
Conclusion: All three models demonstrated good calibration and discrimination for the prediction of in-hospital
mortality following elective AAA repair and are potentially useful. The BAR score has a number of advantages,
which include being developed on the most contemporaneous data, excellent overall discrimination, and good
performance in procedural subgroups. Regular model validations and recalibration will be essential.
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making, and to risk-adjust clinical outcome data. Accurate risk
prediction models are particularly important for elective
abdominal aortic aneurysm (AAA) repair. First, because most
patients with AAA are asymptomatic, with an increasing
numberof patients identiﬁed through screening programmes,
accurate estimates of procedural risk are important for opti-
mising clinical decision-making. Second, named individual
surgeon outcomes following elective AAA repair have recently
been published in the UK.1 Risk-adjusting published surgical
outcome data is essential if fair comparisons between
Table 1. Risk factors included in the British Aneurysm Repair (BAR)
score, Medicare model, and Vascular Governance Northwest
(VGNW) model.
Bar score Medicare model VGNW model
Open repair Open repair Open repair
Age (continuous) Age (grouped) Age (continuous)
Female sex Female Female
Creatinine
>120 mmol/L
Chronic renal
disease
Creatinine
(continuous)
Cardiac disease End-stage renal disease Diabetes
Abnormal ECG Cardiac failure Antiplatelet
medication
Previous aortic
surgery/stent
Vascular disease Respiratory
disease
Abnormal white
cell count
Abnormal sodium
AAA diameter
(cm)
ASA grade (IeIV)
Note. ECG ¼ electrocardiogram; AAA ¼ abdominal aortic
aneurysm; ASA ¼ American Society of Anesthesiologists.
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averse clinical decisions avoided.
A number of risk prediction models have previously been
developed for AAA repair.2 However, unlike in cardiac sur-
gery, where risk prediction models have been widely
accepted and utilised in clinical practice,3 risk models have
never been widely used in AAA repair. Reasons for this lack
of adoption include doubts about the accuracy and appli-
cability of models to contemporary practice, lack of vigorous
model validation, the inability to easily perform model
calculations and uncertainty over how such models might
be used in clinical practice.
To address the lack of suitable risk models, a number of
models have recently been developed, including the British
Aneurysm Repair (BAR) score, and the Medicare and
Vascular Governance Northwest (VGNW) models.4e6 All
three models have been developed speciﬁcally for elective
AAA repair and have demonstrated potential accuracy in
validation studies performed to date.7e9 Surgical risk
models can lose accuracy over time as practices change and
outcomes improve.10 Therefore, if a model is to be rec-
ommended for use in clinical practice, it is important that it
has been validated and found to be accurate for contem-
porary practice. Therefore, the objective of this study was to
perform a contemporary prospective validation of the
Medicare, VGNW, and BAR risk models.
MATERIALS AND METHODS
This was a prospective, multicentre study conducted on
behalf of VGNW, a peer-led clinical governance programme
that audits the results of vascular surgeons across the
north-west of England and Wales. Data were collected on
consecutive elective AAA repairs performed between April
2011 and March 2013. As only pseudonymous, non-
identiﬁable data were used for this study, ethical approval
was not required. Elective procedures were deﬁned by the
timing of surgery rather than the mode of admission. Data
collected included patient demographics, comorbidities,
preoperative medications, preoperative investigations,
procedural details and clinical outcomes.
Patient characteristics were deﬁned as follows: ischaemic
heart disease included a history of angina, previous
myocardial infarction or previous coronary revascularisa-
tion; respiratory disease was deﬁned as the presence of
chronic respiratory disease with dyspnoea on exertion or at
rest; diabetes included any patient receiving treatment for
diabetes (diet controlled, noninsulin- and insulin-
dependent). Medications were recorded if they were be-
ing taken by the patient on admission for surgery. Abnormal
electrocardiogram was recorded if there was evidence of
any of the following; atrial ﬁbrillation or any other abnormal
rhythm; > 5 ectopic beats/minute; Q or ST/T wave changes.
Abnormal laboratory investigations were deﬁned as serum
sodium <135 or >145 mmol/L; serum potassium <3.5 or
>5.5 mmol/L; urea >7.5 mmol/L; white cell count
<3.0  109/L or >11.0  109/L; and haemoglobin <11 g/
dL for women and <13 g/dL for men. Activity and outcome
data for the VGNW programme are validated againstHospital Episode Statistic data by the VGNW team, with risk
factor data also validated where possible.
Data were cleaned by removing duplicate records, cor-
recting transcriptional discrepancies, and resolving any
clinical or temporal conﬂicts. Missing data were imputed
with the sample median for continuous or ordinal variables,
and the mode for dichotomous variables. Thoraco-
abdominal or isolated iliac aneurysm repairs were
excluded from the analysis. The primary outcome measure
for the study was in-hospital mortality, deﬁned as death due
to any cause during admission for elective AAA repair.
Following risk factor imputation, the Medicare, VGNW, and
BAR scores were calculated for each record. Risk factors
included in each model are shown in Table 1.
Model performance was assessed using measures of
calibration and discrimination in the overall cohort and
separately in both procedural and gender subgroups.
Discrimination was evaluated by determining the receiver
operating characteristic (ROC) curve, which is summarized
by the area under the curve (AUC) alongside an approxi-
mate 95% conﬁdence interval (CI). An AUC of 0.9 is
deﬁned as “outstanding”, an AUC of 0.8e0.9 is considered
“excellent”, an AUC of 0.7e0.8 represents “acceptable”
discrimination, and an AUC of 0.5 represents no
discrimination.11
In the overall cohort and procedural subgroups, model
calibration has been summarised by calculating the
observed to expected (O:E) ratio and an exact 95% CI. If, on
average, the model is well calibrated, then the O:E ratio
should be close to 1. If the O:E is above or below 1 this
indicates under- and over-prediction respectively. Model
calibration has been further assessed in the overall cohort
by dividing the cohort into low (bottom 50%), medium
(middle 25%), and high-risk (top 25%) groups based on the
model’s predicted mortality. Model performance statistics
were calculated for each risk group. Calibration plots for
Table 2. Characteristics of the study population.
Risk factor Frequency (%) Missing
data (%)
Age (years)a 74.4 (7.7) 0.2
Female sex 193 (17.2) 0.0
AAA diameter
(cm)a
6.3 (1.2) 6.0
Previous aortic
surgery/stent
67 (6.0) 1.3
AAA symptoms 87 (7.7) 6.1
Ischaemic heart
disease
357 (31.8) 8.5
Previous
myocardial infarction
163 (14.5) 8.5
Cardiac failure 27 (2.4) 9.2
Respiratory disease 199 (17.7) 14.5
Diabetes 162 (14.4) 3.2
Antiplatelet medication 716 (63.7) 0.5
Antihypertensive
medication
371 (33.0) 0.5
Statin therapy 778 (69.2) 0.4
Smoking status e 12.2
Ex-smoker 298 (26.5) e
Current smoker 246 (21.9) e
Abnormal ECG 359 (31.9) 5.7
Abnormal sodium 105 (9.3) 11.0
Abnormal potassium 36 (3.2) 10.4
Abnormal urea 308 (27.4) 10.4
Creatinine >120 mmol/L 186 (16.5) 10.1
Creatinine >200 mmol/L 21 (1.9) 10.1
Abnormal WCC 82 (7.3) 9.0
Abnormal haemoglobin 296 (26.3) 9.0
ASA grade e 11.4
I 56 (5.0) e
II 434 (38.6) e
III 604 (53.7) e
IV 30 (2.7) e
Open repair 365 (32.5) 0.0
40 S.W. Grant et al.each model based on these groups were produced showing
the mean predicted probability of outcome against the
observed proportion of outcomes. Approximate 95% CIs for
the observed mortality proportions in each group are
shown as error bars in the ﬁgures.
The calibration intercepts and slope parameters were
also calculated for each model in the overall cohort. The
calibration intercept and slope are calculated by ﬁtting a
logistic regression model with the dependent variable set as
the observed outcome and the independent variable set as
the log-odds (“logit”) transformed model prediction. If the
model was perfectly calibrated the intercept and slope
would equal 0 and 1 respectively. The intercept is a measure
of overall model calibration, which is whether predictions
agree on average with observed probabilities. A chi-square
test (on 2 degrees of freedom) for “unreliability” (null hy-
pothesis: intercept ¼ 0 and slope ¼ 1) was also per-
formed.12 All p-values <.05 were considered signiﬁcant. All
statistical analyses were performed using R version 3.0.2.13
RESULTS
Patient characteristics
Data were available for 1,142 procedures performed by 60
surgeons at 17 different hospitals. Sixteen procedures were
excluded as they related to either thoracic or isolated iliac
aneurysm repairs, with two further records excluded as
there was evidence that the procedure was nonelective.
This resulted in a ﬁnal cohort for analysis of 1,124 elective
AAA repairs. The mean age of the population was 74.4 years
(SD 7.7); 193 (17.2%) patients were women. The majority of
patients (759, 67.5%) underwent endovascular aneurysm
repair (EVAR), and most patients (1,037, 92.3%) were
asymptomatic. Additional patient characteristics are given
in Table 2.Note. AAA¼ abdominal aortic aneurysm; ECG¼ electrocardiogram;
WCC ¼ white cell count; ASA ¼ American Society of
Anesthesiologists.
a Continuous data displayed as mean (SD).Overall model calibration
There were 32 in-hospital deaths in the study cohort, giving
an overall mortality of 2.8%. The Medicare predicted mor-
tality was 2.8%, which was not signiﬁcantly different from
the observed mortality, giving an O:E of 1.02 (95% CI 0.70e
1.44, p ¼ .858). The VGNW predicted mortality was 3.2%,
giving an O:E ratio of 0.89 (95% CI 0.61e1.25, p ¼ .560) and
the BAR score predicted mortality was 2.4%, giving an O:E
ratio of 1.19 (95% CI 0.81e1.68, p ¼ .334). Calibration plots
for the three models are shown in Fig. 1. The calibration
intercepts and slopes also demonstrated good calibration
for all three models, with each unreliability statistic being
insigniﬁcant (Medicare p ¼ .332, VGNW p ¼ .756, BAR
p ¼ .581). Model performance in the low-, medium-, and
high-risk groups, deﬁned based on the probabilities calcu-
lated by each model, is shown in Tables 3e5.Overall model discrimination
The BAR score demonstrated excellent discrimination in the
overall cohort, with an AUC of 0.83 (95% CI 0.76e0.89). The
discriminative ability of the Medicare and VGNW modelswas acceptable, with AUCs of 0.78 (95% CI 0.70e0.86) and
0.75 (95% CI 0.65e0.84) respectively. The ROC curves for
the models in the overall cohort are shown in Fig. 2.
Model performance in separate open AAA repair and EVAR
groups
The in-hospital mortality rates for open AAA repair and
EVAR were 6.8% and 0.9% respectively. The predicted
mortality in the open AAA repair group was 4.4% (O:E 1.56
[95% CI 1.01e2.30], p ¼ .033), 5.4% (O:E 1.26 [95% CI
0.81e1.86], p ¼ .260), and 4.9% (O:E 1.41 [95% CI 0.91e
2.08], p ¼ .095) for the Medicare, VGNW, and BAR scores
respectively. In the EVAR group, the predicted mortality was
2.0% (O:E 0.46 [95% CI 0.18e0.94], p ¼ .029), 2.1% (O:E
0.43 [95% CI 0.17e0.89], p ¼ .017), and 1.2% (O:E 0.76
[95% CI 0.31e1.57], p ¼ .619) for the Medicare, VGNW, and
BAR scores respectively.
Figure 1. Calibration plots for low-, medium-, and high-risk groups
for the British Aneurysm Repair (BAR), Medicare, and Vascular
Governance Northwest (VGNW) risk models. The black dashed line
is the line of equality that represents perfect calibration. Vertical
lines represent approximate 95% binomial conﬁdence intervals of
the observed mortality proportion.
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score demonstrated acceptable discrimination, with an AUC
of 0.70 (95% CI 0.61e0.78). Both the Medicare and VGNW
models demonstrated unacceptable discrimination, with
AUCs of 0.68 (95% CI 0.58e0.78) and 0.64 (95%CI 0.53e
0.75). In the EVAR subgroup only the BAR score demon-
strated acceptable discrimination, with an AUC of 0.75 (95%
CI 0.55e0.95). Both the Medicare and VGNW models
demonstrated unacceptable discrimination with AUCs of
0.66 (95% CI 0.47e0.85) and 0.56 (95% CI 0.31e0.81)
respectively.
Model performance by sex
The in-hospital mortality for men was 2.8% and for women
was 3.1%. The predicted mortality for men was 2.4% (O:E
1.14 [95% CI 0.75e1.67], p ¼ .462), 2.6% (O:E 1.08 [95% CI
0.71e1.59], p ¼ 0.682), and 1.9% (O:E 1.47 [95% CI 0.96eTable 3. Calibration of the Medicare model for low-, medium-, and high
predicted mortality.
Low risk
Predicted mortality ranges 0 < x  2.084
Number of patients, n 611
EVAR, n 534
Open AAA repair, n 77
Observed mortality rate, % 1.1
Expected mortality rate, % 1.3
O:E ratio, 95% CI 0.85 (0.34e1.76)
p 0.861
Note. EVAR ¼ endovascular aneurysm repair; AAA ¼ abdominal aortic2.16], p ¼ .055) for the Medicare, VGNW and BAR scores
respectively. For women, the predicted mortality was 4.5%
(O:E 0.70 [95% CI 0.26e1.52], p ¼ 0.494), 6.2% (O:E 0.50
[95% CI 0.18e1.09], p ¼ .109), and 4.8% (O:E 0.64 [95% CI
0.24e1.40], p ¼ .408) for the Medicare, VGNW and BAR
scores respectively. For men, the BAR score demonstrated
excellent discriminatory ability, with an AUC of 0.85 (95% CI
0.78e0.92). Both the Medicare and VGNW models
demonstrated acceptable discrimination with AUCs of 0.78
(95% CI 0.69e0.86) and 0.76 (95% CI 0.65e0.87) respec-
tively. For women, the Medicare model demonstrated
excellent discriminatory ability with an AUC of 0.88 (95% CI
0.76e0.99). The BAR score and VGNW model both
demonstrated acceptable discrimination with AUCs of 0.79
(95% CI 0.67e0.92) and 0.76 (95% CI 0.53e0.99)
respectively.
DISCUSSION
We evaluated three contemporary risk prediction models
for in-hospital mortality following elective AAA repair, and
demonstrated that all three models are potentially useful.
The BAR score, developed using data from the UK National
Vascular Database demonstrated excellent discriminatory
ability overall and retained acceptable discriminatory ability
in separate open AAA repair and EVAR cohorts. Although
the Medicare and VGNW models demonstrated acceptable
discrimination overall for elective AAA repair, discrimination
was inadequate for open AAA repair and EVAR separately.
All three models demonstrated good calibration in the
overall cohort. However, only the BAR score demonstrated
acceptable calibration in both procedural subgroups.
As with any registry study, data quality and completeness
are inevitable limitations; however, no variable used was
missing in >15% of cases. All required variables were
available as deﬁned for the calculation of the BAR score and
VGNW model; however, for the Medicare model, some risk
factors had to be inferred from related data as the risk
factors as deﬁned were not collected by the VGNW pro-
gramme for the study period. A history of vascular disease
was presumed for patients identiﬁed as taking preoperative
antiplatelet medication. This assumption is likely to have led
to an overestimation in risk for the Medicare model, as only
w31% of patients had vascular disease in the Medicare
cohort compared with the assumed proportion in this study
of 61.7%.5 Chronic renal disease was assumed for any-risk groups; groups were deﬁned according to the Medicare model
Medium risk High risk
2.084 < x  3.230 3.230 < x  32.519
247 266
120 105
127 161
2.4 7.1
2.8 6.1
0.88 (0.32e1.91) 1.16 (0.70e1.82)
1.000 0.457
aneurysm; O:E ¼ observed to expected; CI ¼ conﬁdence interval.
Table 4. Calibration of the Vascular Governance Northwest (VGNW) score for low-, medium-, and high-risk groups; groups were deﬁned
according to the VGNW score predicted mortality.
Low risk Medium risk High risk
Predicted mortality ranges 0 < x  2.089 2.089 < x  3.817 3.817 < x  62.330
Number of patients, n 562 281 281
EVAR, n 487 184 88
Open repair, n 75 97 193
Observed mortality rate, % 1.1 1.8 7.5
Expected mortality rate, % 1.2 2.8 7.6
O:E ratio (95% CI) 0.88 (0.32e1.92) 0.63 (0.20e1.46) 0.99 (0.61e1.51)
p 1.000 0.375 1.000
Note. EVAR ¼ endovascular aneurysm repair; O:E ¼ observed to expected; CI ¼ conﬁdence interval.
42 S.W. Grant et al.patient with a creatinine >120 mmol/L and end-stage renal
disease assumed for any patient with a creatinine
>200 mmol/L. This assumption led to similar proportions of
patients being classiﬁed as having renal disease in this study
as in the cohort used for development of the Medicare
model.
This study was based on prospectively collected, vali-
dated clinical audit data from multiple centres throughout
the north-west of England and Wales. A comprehensive
assessment of each model’s performance with regard to
discrimination, calibration, and clinical validity has been
performed. Good model discrimination is important, as this
tends to remain stable over time, and poor discriminatory
performance is difﬁcult to correct.10,14 Adequate calibration
of a model is, perhaps, more essential for clinical decision-
making and risk adjustment of surgical outcome data.15
Unlike poor discrimination, if a model is poorly calibrated
this can potentially be addressed using a variety of
methods.16 Although good calibration was demonstrated
overall, both the Medicare and VGNW models demon-
strated over-prediction of risk in patients undergoing EVAR,
and the Medicare model also under-predicted risk for open
AAA repair.
A trend towards under-prediction of risk in high-risk pa-
tients was demonstrated by the Medicare model and BAR
score, while all three models tended to under-predict risk in
men and over-predict risk in women. However, a limitation
of this study is that the relatively small numbers of out-
comes, particularly for the subgroup analyses, may have led
to substantial differences in model performance not being
detected.17 It is necessary that these models be tested on
larger datasets in order to conﬁrm their performance inTable 5. Calibration of the British Aneurysm Repair (BAR) score for low-
the BAR score predicted mortality.
Low risk
Predicted mortality ranges 0 < x  1.245
Number of patients, n 562
EVAR, n 496
Open repair, n 66
Observed mortality rate, % 0.4
Expected mortality rate, % 0.7
O:E ratio (95% CI) 0.52 (0.06e1.88)
p 0.603
Note. EVAR ¼ endovascular aneurysm repair; O:E ¼ observed to expespeciﬁc subgroups. The number of outcomes available also
meant it was not possible to perform an overall Hosmere
Lemeshow test.11
Clinical validity of the models is suggested by the risk
factors that are included in all three models, including open
repair, age, female sex, and renal disease. Cardiac disease is
included in both the BAR score and Medicare model, and
vascular disease (identiﬁed in the VGNW model by use of
antiplatelet medication) is present in the Medicare and
VGNW models. Diabetes and respiratory disease are exclu-
sive to the VGNW model, while previous aortic surgery or
stent, abnormal white cell count, abnormal sodium, AAA
diameter (cm), and American Society of Anesthesiologists
grade (IeIV) are exclusive to the BAR score. Potential rea-
sons for differences in risk factors between the models
include the size of the dataset available for model devel-
opment, the availability of each risk factor, differences in
the time interval of data collection, difference in the pop-
ulations studied between development datasets and dif-
ferences in risk factor deﬁnitions.
In addition to differences in risk factors included in the
models there are also differences in the outcomes themodels
were designed to predict. The BAR score was developed to
predict in-hospital mortality, whereas the VGNW model was
designed to predict 30-day mortality. The Medicare model
was developed to predict either in-hospital mortality or
30-day mortality. These differences in outcome deﬁnitions
are unlikely to affect model performance signiﬁcantly as in
this study no deaths occurred after discharge, but within 30
days of the procedure. Clearly, perioperative mortality is an
important outcome for patients, surgeons, and healthcare
providers, and is also the outcome currently used for, medium-, and high-risk groups; groups were deﬁned according to
Medium risk High risk
1.245 < x  2.540 2.540 < x  44.335
281 281
196 67
85 214
1.8 8.9
1.8 6.4
1.00 (0.32e2.33) 1.38 (0.89e2.04)
1.000 0.124
cted; CI ¼ conﬁdence interval.
Figure 2. Receiver operating characteristic curves for the British
Aneurysm Repair (BAR), Medicare, and Vascular Governance
Northwest (VGNW) risk models in the overall cohort. The grey line
represents the line of equality.
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other important outcomes, such as re-intervention, long-
term survival, and aneurysm-related mortality are key in-
dicators of quality and may be used in the publication of
surgical outcome data going forward.
Both the VGNW and Medicare models have previously
been validated using multicentre and single-centre data and
found to perform acceptably with regard to discrimination
and calibration.7e9 This study represents the second suc-
cessful external validation of the BAR score, with the pre-
vious validation performed using data from a randomised
clinical trial.9 All the models studied have been developed
within the last 5 years; however, the development datasets
cover signiﬁcantly different time periods, which may ac-
count for differences in model performance. The datasets
used to develop the VGNW model and Medicare model are
relatively out of date with respect to modern vascular sur-
gical practice represented in this cohort. With regard to the
type of data used for model development, the BAR score
and VGNW model were built using clinical datasets, and the
Medicare model was developed using administrative data.
It has been suggested that using clinical datasets for risk
model development is more appropriate than using
administrative datasets.18,19
Unlike some older models for AAA repair,20e22 all three
models were based on datasets that included exclusively
AAA repairs (both open repairs and EVAR). Although the
BAR score demonstrates acceptable performance for sepa-
rate EVAR and open cohorts, it is possible that models
designed speciﬁcally for either open repair or EVAR may
have improved performance for these procedures sepa-
rately. However, a combined model approach is potentially
more suitable for clinical practice as it allows the easycalculation of the risk of both procedures and is more
appropriate for risk-adjustment purposes.
Although all three models validated here are potentially
useful, in our opinion the BAR score is the most appropriate
for informing clinical decision-making and risk-adjusting
surgical outcome data in elective AAA repair. Although,
overall, a statistically signiﬁcant superior performance of
the BAR score has not been demonstrated, it was the only
model to retain acceptable discrimination and calibration in
both EVAR and open repair subgroups. The BAR score is also
based on the most contemporary data, and can be easily
accessed and calculated in <30 seconds using either a
website (www.britishaneurysmrepairscore.com) or an App
(via the Apple App Store or Google Play).
When using a model in clinical decision-making it is
important that the clinician should (i) understand that the
risk prediction model does not predict the outcome for an
individual patient, but provides an estimate of the risk for a
population of patients with similar characteristics under-
going the same procedure; (ii) understand any potential
limitations of the model; (iii) know how their own perfor-
mance may inﬂuence the prediction; and (iv) adjust the
prediction based on important risk factors not captured in
the model. As risk prediction models tend to lose calibration
over time,10 it is vital that models are validated every 2e3
years and recalibrated. This approach allows new risk fac-
tors to be incorporated into updated models to potentially
further improve model performance. Dynamic modelling is
an alternative approach that could be adopted to address
calibration, but would require improved data collection and
informatics infrastructure.23
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